Received Mar 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | ER8731 | — |
blood clots in my popliteal vein and lower limbs; blood clots in my popliteal vein and lower limbs; This is a spontaneous report received from a Consumer or other non HCP. A 20-year-old male patient received BNT162b2 (BNT162B2), on 16Apr2021 as dose 2, single (Lot number: ER8731) at the age of 16 years for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE; Lot number: Ep7534), administration date: 19Mar2021, when the patient was 16-year-old, for COVID-19 Immunization. The following information was reported: DEEP VEIN THROMBOSIS (hospitalization, medically significant), PERIPHERAL ARTERY THROMBOSIS (hospitalization) all with onset 11Feb2025, outcome "recovering" and all described as "blood clots in my popliteal vein and lower limbs". Therapeutic measures were taken as a result of deep vein thrombosis, peripheral artery thrombosis included Eliquis. Clinical course: 3 weeks ago, the patient was diagnosed with blood clots in his popliteal vein and lower limbs.
Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None